Package 68001-345-26

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68001-345-26
Digits Only 6800134526
Product NDC 68001-345
Product ID 68001-345_e9b9ead5-4033-1599-e053-2a95a90a0d81
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (68001-345-26) / 25 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2018-02-16
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

Doxorubicin Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "e9b9ead5-4033-1599-e053-2a95a90a0d81", "openfda": {"upc": ["0368001345361", "0368001345262"], "unii": ["82F2G7BL4E"], "rxcui": ["1790115", "1790127"], "spl_set_id": ["f1a12eb5-5bdc-45f4-843e-0c971535b184"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68001-345-26)  / 25 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68001-345-26", "marketing_start_date": "20180216"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68001-345-36)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68001-345-36", "marketing_start_date": "20180216"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "68001-345_e9b9ead5-4033-1599-e053-2a95a90a0d81", "dosage_form": "INJECTABLE, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "68001-345", "generic_name": "Doxorubicin Hydrochloride", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA208657", "marketing_category": "ANDA", "marketing_start_date": "20180216", "listing_expiration_date": "20261231"}